Regenxbio Inc (RGNX)
Gross profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | -52,366 | -48,113 | -53,389 | -47,067 | -57,064 | 247,682 | 270,322 | 284,169 | 313,404 | 23,607 | 163,512 | 169,432 | 172,121 | 165,565 | 25,463 | 6,239 | -13,464 | 18,851 | 6,163 | 45,327 |
Revenue (ttm) | US$ in thousands | 85,585 | 89,565 | 82,833 | 89,765 | 89,470 | 395,745 | 424,505 | 432,813 | 446,605 | 134,740 | 275,433 | 273,347 | 271,089 | 261,412 | 95,283 | 71,153 | 44,415 | 73,424 | 54,848 | 86,998 |
Gross profit margin | -61.19% | -53.72% | -64.45% | -52.43% | -63.78% | 62.59% | 63.68% | 65.66% | 70.17% | 17.52% | 59.37% | 61.98% | 63.49% | 63.33% | 26.72% | 8.77% | -30.31% | 25.67% | 11.24% | 52.10% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-52,366K ÷ $85,585K
= -61.19%
Regenxbio Inc's gross profit margin has exhibited some fluctuations over the past eight quarters. In Q4 2023, the gross profit margin was 58.76%, showing a decrease compared to the previous quarter. However, it is important to note that the Q4 2023 gross profit margin is still within a reasonable range.
Looking at the trend over the past quarters, there was a significant drop in the gross profit margin in Q4 2022 to 51.61%, followed by a substantial increase in Q3 2022 to 88.02%. Since then, the gross profit margin has been relatively stable around the 60-70% range.
It is essential to investigate the factors driving these fluctuations in the gross profit margin, such as changes in revenue, cost of goods sold, pricing strategies, or production efficiencies. A declining gross profit margin could indicate decreasing profitability or increasing costs that need to be addressed by the company.
Overall, the historical data on Regenxbio Inc's gross profit margin highlights the importance of regularly monitoring and analyzing this metric to assess the company's financial performance and efficiency in generating profits from its core activities.
Peer comparison
Dec 31, 2023